Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 75.32
+1.84 (2.50%)
Apr 24, 2025, 2:45 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 30.51 billion as of April 24, 2025. Its market cap has increased by 12.71% in one year.
Market Cap
30.51B
Enterprise Value
29.71B
Revenue
2.95B
Ranking
n/a
PE Ratio
34.76
Stock Price
75.32
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 30.51B, an increase of 112.46%. That is a compound annual growth rate of 15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 29.89B | 0.15% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 324.10B |
| Shenzhen Mindray Bio-Medical Electronics | 265.58B |
| WuXi AppTec | 156.35B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.36B |
| Aier Eye Hospital Group | 119.65B |
| Shanghai United Imaging Healthcare | 105.56B |
| Sichuan Biokin Pharmaceutical | 104.93B |
| Yunnan Baiyao Group Co.,Ltd | 102.08B |